Growth factor receptor-binding proteins Grb7, Grb10 and Grb14 are adaptor proteins containing a Ras-associating (RA) domain, a pleckstrin-homology (PH) domain, a family-specific BPS (between PH and SH2) region and a C-terminal Src-homology-2 domain. Previous structural studies showed that the Grb14 BPS region binds as a pseudosubstrate inhibitor in the tyrosine kinase domain of the insulin receptor to suppress insulin signaling. Here we report the crystal structure of the RA and PH domains of Grb10 at 2.6-Å resolution. The structure reveals that these two domains, along with the intervening linker, form an integrated, dimeric structural unit. Biochemical studies demonstrated that Grb14 binds to activated Ras, which may serve as a timing mechanism for downregulation of insulin signaling. Our results illuminate the membrane-recruitment mechanisms not only of Grb7, Grb10 and Grb14 but also of MIG-10, Rap1-interacting adaptor molecule, lamellipodin and Pico, proteins involved in actin-cytoskeleton rearrangement that share a structurally related RA-PH tandem unit.
Grb7, Grb10 and Grb14 are related adaptor proteins that comprise an N-terminal region containing polyproline stretches, an RA domain, a PH domain, a family-specific BPS region and a C-terminal SH2 domain 1, 2 (Fig. 1a) . Using various biochemical approaches, these adaptor proteins have been shown to be capable of binding to various receptor tyrosine kinases, including the insulin and insulin-like growth factor-1 (IGF1) receptors 1, 2 . Important insights into the true biological roles of Grb10 and Grb14 have come from gene-deletion studies in mice. The Grb10 gene is maternally imprinted in mice, and loss of the maternal allele results in mice that are approximately 30% greater in size than wild-type littermates, with disproportionately large livers 3 . As adults, these mice show improved glucose tolerance, increased muscle mass and reduced adiposity 4, 5 . Transgenic mice overexpressing Grb10 show postnatal growth retardation and insulin resistance as a consequence of hypernegative regulation of the insulin and IGF1 receptors 6 . Male Grb14 À/À mice are of normal size and show improved glucose tolerance and enhanced insulin signaling in muscle and liver 7 . These in vivo studies established that Grb10 and Grb14 are important tissue-specific negative regulators of insulin and IGF1 signaling.
Accumulating evidence suggests that Grb10 and Grb14 might contribute to type 2 (non-insulin-dependent) diabetes in humans. In the ob/ob mouse model for type 2 diabetes, Grb14 mRNA levels were increased by 75-100% in adipose tissue, and in type 2 diabetic patients Grb14 mRNA levels were elevated by 43% in subcutaneous adipose tissue compared with nondiabetic control patients 8 . In a genome-wide association scan of an Amish population, the strongest association between type 2 diabetes and a single-nucleotide polymorphism was in the GRB10 gene 9 .
We previously showed that the BPS region of Grb14 binds as a pseudosubstrate in the active site of the insulin receptor kinase to suppress substrate phosphorylation and thus downregulate insulin signaling 10 . The Grb14 SH2 domain binds to the phosphorylated activation loop of the kinase to increase the affinity and specificity of the Grb14-insulin receptor interaction 10 . In an effort to understand the roles of the RA and PH domains of Grb10 and Grb14 in inhibition of insulin signaling, we determined the crystal structure of the tandem RA and PH domains of human Grb10. The structure reveals that these two domains, along with the B40-residue intervening linker, form an integrated RA-PH structural unit, which is dimerized via a helical extension of the PH domain. We provide evidence that Grb14 is a more potent inhibitor of insulin signaling than Grb10, and that both phosphoinositide and GTPase binding are crucial for downregulation of insulin signaling by Grb14. Our structural and biochemical data yield insights into the mechanisms of membrane recruitment not only for Grb7, Grb10 and Grb14, but also for the so-called MRL proteins 11 : MIG-10 12 , Rap1-interacting adaptor molecule (RIAM) 13, 14 , lamellipodin 15 and Pico 16 , which are Ena/VASP-binding adaptor proteins predicted to possess a similar RA-PH structural unit.
RESULTS
Crystal structure of Grb10 RA-PH We engineered an Escherichia coli expression construct to encode residues 106-357 of human Grb10, comprising the RA and PH domains, with a His 6 tag included on the N terminus. Initial sizeexclusion chromatography experiments on purified protein indicated that adventitious disulfide bond formation was occurring (ten cysteines in this construct), leading to dimerization and higher-order oligomerization, despite the presence of reducing agent. To suppress disulfide bond formation, we introduced four cysteine to serine substitutions (see Online Methods), based on their solvent exposure in the available structures of individual RA and PH domains. After these substitutions the protein ran as a single monomeric species on a sizeexclusion column. This protein was nevertheless refractory to crystallization, and we introduced two additional substitutions at presumed surface residues of the PH domain (K270A and E271A) to facilitate lattice interactions 17 . These substitutions did not affect phosphoinositide binding in vitro (data not shown). We obtained crystals of this protein in monoclinic space group C2 with two Grb10 RA-PH molecules in the asymmetric unit (Ala270 and Ala271 are, in fact, in lattice contacts). The structure was determined by SAD phasing of selenomethionyl (SeMet)-substituted protein crystals, and the structure was refined at 2.6-Å resolution. Data collection and refinement statistics are given in Table 1 . Although disulfide bond formation was apparently not an obstacle to crystallization of Grb14 RA-PH (only four cysteines, no evidence of disulfide formation), we were unable to obtain crystals of wild-type Grb14 RA-PH or the double mutant K272A E273A.
The crystal structure of Grb10 RA-PH reveals canonically folded RA and PH domains with two exceptional features: an extensive interface between the two domains and the intervening linker, and a dimerized RA-PH unit via a C-terminal helical extension of the PH domain (Fig. 1b) . The RA domain adopts the ubiquitin-like fold observed for other RA domains such as those from c-Raf 18 and RalGDS 19 , comprising a five-stranded b-sheet and three short a-helices.
The Grb10 PH domain comprises a sevenstranded (antiparallel) b-sandwich and a C-terminal a-helix. In contrast to canonical PH domains, which terminate after the C-terminal helix (a1), the polypeptide chain in the Grb10 PH domain undergoes an approximately 901 turn after this helix, facilitated by the conserved Gly342, and then forms a two-turn a-helix (a2; Fig. 1b ). This helical extension to the Grb10 PH domain is involved in dimerization of RA-PH ( Fig. 1c and detailed below).
The RA and PH domains are adjoined through an antiparallel b-strand interaction, involving b4 of the RA domain with b5 of the PH domain. The RA-PH interface buries a total surface area of 1,326 Å 2 and is fortified by a number of van der Waals and hydrogen bonding interactions. Two hydrophobic residues from each domain-Leu160 and Leu162 (RA) and Phe287 and Leu318 (PH)-interdigitate to form a small hydrophobic cluster in the interface ( Fig. 1d and Supplementary  Fig. 1 (electron density map) ). The hydrophobicity of these residues is conserved in Grb7, Grb10 and Grb14 ( Fig. 2a ) and in the MRL proteins ( Supplementary Fig. 2 ). In 'stand-alone' RA and PH domains, the corresponding residues are typically hydrophilic. A salt bridge is made between Glu167 (RA) and Arg337 (PH), both of which are conserved in Grb7, Grb10 and Grb14 and in the MRL proteins, and several hydrogen bonding interactions are present in the interface. Limited trypsin digestion of Grb10 and Grb14 RA-PH, which separates the two domains, followed by size-exclusion chromatography confirmed the physical association of the domains (data not shown). In this configuration of the RA and PH domains, both the Ras (or other small GTPase) binding site in the RA domain and the phosphoinositide binding site in the PH domain are accessible ( Fig. 1b , note positions of labels 'RA' and 'PH').
The linker between the RA and PH domains of Grb10 comprises approximately 40 residues that are well conserved in Grb7, Grb10 and and Grb14 drawn to linear scale (human Grb10, isoform c, 536 residues). P, proline-rich region; RA, Ras-associating domain; PH, pleckstrinhomology domain; BPS, between PH and SH2 region; SH2, Src-homology-2 domain. (b) Ribbon diagram of the crystal structure of Grb10 RA-PH. One copy of RA-PH is colored violet (RA) and cyan (PH), and the second copy is colored orange (RA) and green (PH). For both copies, the RA-PH linker is gray. The binding sites for small GTPases on the RA domain and phosphoinositides on the PH domain (noncanonically) are indicated by the position of the labels 'RA' and 'PH'. An approximate twofold axis (vertical, in the plane of the figure) relates the two molecules in the asymmetric unit. Select secondary-structure elements are labeled, as are the N and C termini. Right, the structure has been rotated 901, as indicated, with the molecular twofold axis perpendicular to the plane of the figure. Grb14 ( Fig. 2a ), but less conserved in the MRL proteins (Supplementary Fig. 2 ). In the Grb10 RA-PH structure, residues in the linker form two short a-helices and one b-strand, the latter of which augments (in an antiparallel fashion) b1 of the PH domain. The linker interacts primarily with the PH domain and its C-terminal helical extension (a2) via the Grb7-, Grb10-and Grb14-conserved (hydrophobicity) residues Tyr194, Phe196, Phe197, Phe203, Phe204, Met208, Val209, Leu223, Leu224, Phe227 and Leu228 ( Supplementary Fig. 3 ). These contacts evidently stabilize the position of a2 for dimerization.
In the crystal structure, the two RA-PH molecules in the asymmetric unit are related by an approximate two-fold axis (1741 rotation, 0.5-Å translation). The dimerization interface buries a total surface area of 1,566 Å 2 , and the contributing residues are mainly from the C-terminal helical extension (a2) of the PH domain (Met343, Leu344, Tyr346, Gln347, Asn348 and Arg350) and also from the RA-PH linker (Gln224 and Asn228) ( Fig. 1c) . These residues are relatively well conserved in Grb7, Grb10 and Grb14 ( Fig. 2a) . At high loading concentrations (420 mg ml À1 ), a dimer peak that is small relative to the monomer peak is evident by size-exclusion chromatography, suggesting that the K d for dimerization in solution is relatively high (see Discussion). A double-alanine substitution (Q347A N348A) in the dimer interface suppresses dimer formation ( Supplementary Fig. 4 ).
Phosphoinositide binding to Grb10 and Grb14
Because most PH domains bind to membrane phosphoinositides, we characterized the phosphoinositide-binding specificities of Grb10 and Grb14 RA-PH using BODIPY TMR-conjugated phosphoinositides in a fluorescence-polarization assay 20 . Grb10 RA-PH bound to several phosphoinositides-PI(5)P, PI(4,5)P 2 , PI(3,4)P 2 , and PI(3,4,5)P 3 -with affinities (K d values) in the 4-10 mM range, and bound poorly to all others ( Fig. 3a and Table 2 ). These data indicate that the Grb10 PH domain binds relatively nonspecifically to phosphoinositides and with modest affinities, characteristics that are common among PH domains 21 .
Using the same fluorescence-polarization assay, we also measured the phosphoinositide binding constants for Grb14 RA-PH ( Fig. 3b and Table 2 ). Despite 64% sequence identity in the PH domains of Grb10 and Grb14, the Grb14 PH domain bound to phosphoinositides with lower affinity. The best binder was PI(3,4,5)P 3 with a K d of 28 mM. All other phosphoinositides bound weakly with K d values 4 90 mM.
Most phosphoinositide-binding PH domains engage the headgroup 'atop' the loop connecting the b1 and b2 strands ( Fig. 3c) . A subset of PH domains, including b-spectrin 22 , Tiam1 and ArhGAP9 (ref. 20) , bind headgroups via a noncanonical mode, in which the headgroup binds on the 'side' of b2 and interacts with the b5-b6 loop as well ( Fig. 3d) . A sequence alignment of Grb10 and Grb14 with various PH domains ( Fig. 2b) lysine or arginine two residues C-terminal to a buried hydrophobic residue in b1 (Leu239 in Grb10) ( Fig. 2b) . In Grb10, Grb14 and ArhGAP9, a hydrophobic residue is positioned here (Val241 in Grb10). Noncanonically binding PH domains usually contain instead a basic residue three residues C-terminal to the conserved hydrophobic residue, as do Grb10 (Lys242) and Grb14 (Lys244). Notably, the next residue in Grb10 and Grb14 is a glutamic acid (Glu243 and Glu245 in Grb10 and Grb14, respectively), which would be predicted to hinder headgroup binding at the canonical site, both sterically and electrostatically ( Fig. 3c) . b-spectrin and ArhGAP9 also contain residues with large (although not acidic) side chains at this position. In Grb7, this residue is a glycine, as in Grp1 and Akt, which bind PI(3,4,5)P 3 canonically.
In the b5-b6 loop, there is less sequence similarity between b-spectrin, ArhGAP9 and Grb7, Grb10 and Grb14 (Fig. 2b) , and it is therefore more difficult to predict which residues in the b5-b6 loop of the Grb proteins might be involved in binding headgroups noncanonically. Although there are several basic residues in this loop in Grb7, Grb10 and Grb14, their positioning in the Grb10 RA-PH structure indicates that they are unlikely to interact directly with phosphate groups of the headgroup. One residue in the b5-b6 loop of Grb10 that seems to be positioned for headgroup binding is Asn297, which is a glycine in Grb14.
Unfortunately, we were unable to cocrystallize (or soak) Grb10 RA-PH with various phosphoinositide headgroups. To explore the phosphoinositide binding modes used by Grb10 and Grb14, we introduced several individual point mutations into Grb10 and Grb14 RA-PH and measured phosphoinositide binding using the fluorescencepolarization assay. The results are presented in Table 2 . Three lysineto-alanine mutations were made in the b1-b2 loop of Grb10: K242A, K247A and K250A. Lys242 and Lys247 are positioned to interact with headgroups only in the noncanonical binding mode (Fig. 3d) , and these mutations resulted in approximately a twofold and fivefold loss of binding, respectively ( Table 2) . Lys250 could interact with the 1-phosphate group in either binding mode (canonical or noncanonical), and mutation to alanine also resulted in a five-fold loss of binding.
The case for noncanonical binding is strengthened by the N297G mutation in the b5-b6 loop of the Grb10 PH domain, which also resulted in a fivefold loss of binding ( Table 2) , and the E243G L244S mutation in the b1-b2 loop, which had no appreciable effect on headgroup binding, but would be predicted to increase canonical binding in the absence of an alternative binding mode (Fig. 3c) . In Grb14, this same mutation resulted in a four-fold increase in PI(3,4,5)P 3 binding, whereas replacement of Gly299 with asparagine (b5-b6 loop) did not result in higher (Grb10-like) binding affinities. The mutation K252A in Grb14 (K250A in Grb10) decreased PI (3, 4, 5) binding affinity by more than three-fold ( Table 2) .
Ras binding to Grb10 and Grb14
Previous pull-down experiments using cell lysates demonstrated that Grb7 (Grb10 and Grb14 were not tested) binds to activated Ras (N-Ras, Figure 3 Binding of phosphoinositides to Grb10 and Grb14 RA-PH. (a) Representative fluorescence-polarization measurements (millipolarization (mP) versus protein concentration) of phosphoinositide binding to wild-type Grb10 RA-PH. Fits are based on a saturable, single-site binding model. K d values (in mM) extracted from the fits are given in parentheses to the right of the headgroup labels. Complete results are given in Table 2 . (b) Same as a but for Grb14 RA-PH. (c) Comparison of the PH domains of Grb10 and Grp1. Residues in b1 and b2 were superimposed and, for clarity, only b1-b2 and b5-b6 are shown. Grb10 is colored cyan, and Grp1 (PDB 1FGY) 24 is colored brown with the canonically bound Ins(1,3,4,5)P 4 headgroup (semitransparent) colored yellow (carbon atoms), red (oxygen atoms) and black (phosphorus atoms). The phosphate positions on the inositol ring are labeled. Residues in Grb10 that were mutated in this study are shown in stick representation and labeled. Relative to Grp1, Grb10 contains a 6-residue insertion in the b5-b6 loop. (d) Comparison of the PH domains of Grb10 and ArhGAP9. Residues in b1 and b2 were superimposed (identical orientation as in c). ArhGAP9 (PDB 2P0H) 20 is colored green with the noncanonically bound Ins(1,3,4)P 3 headgroup (semitransparent) colored as in c. Relative to Grb10, ArhGAP9 contains a 6-residue insertion in the b1-b2 loop and a 5-residue deletion in the b5-b6 loop. K-Ras and H-Ras) and much more weakly to activated Rap1 and Rap2 (ref. 26) . In a similar fashion, we co-transfected HEK 293T cells with hemagglutinin-tagged, wild-type N-Ras or a constitutively active mutant (G12D), along with Myc-tagged Grb7, Grb10 or Grb14 (all full length), immunoprecipitated N-Ras with an anti-hemagglutinin antibody and immunoblotted for Grb7, Grb10 or Grb14 using an anti-Myc antibody. This co-immunoprecipitation experiment (Fig. 4a ) demonstrated that Grb14, like Grb7, interacts with N-Ras, but that Grb10 interacts comparatively weakly. This experiment also showed that Grb7, Grb10 and Grb14 bind preferentially to activated N-Ras. Pulldown experiments using lysates of HEK 293T cells co-transfected with either constitutively active N-Ras, Rap1 or Rap2 (GST fusions) and Grb10 or Grb14 demonstrated that Grb10 and Grb14 do not bind appreciably to Rap1 or Rap2 relative to N-Ras (data not shown).
A point mutation in the Grb14 RA domain, K140A (Lys142 in Grb10), was introduced to verify that the mode of binding of the Grb14 RA domain to activated Ras is similar to that of other RA domain-GTPase interactions, for example, that of RalGDS RA domain with Ras 27 . Indeed, this mutation disrupted the interaction between Grb14 and N-Ras, as evidenced by the loss of co-immunoprecipitation ( Fig. 4b) .
To determine whether the PH domain is important for the interaction of Grb14 with Ras, we tested the binding of Grb14 K252A to Ras. This mutation in Grb14 RA-PH resulted in loss of binding of phosphoinositide headgroups in vitro ( Table 2 ). The reduced co-immunoprecipitation with Ras for this PH-domain mutation (Fig. 4b) indicates that Grb14 membrane association, mediated by the PH domain, is important for the interaction of Grb14 with Ras.
Grb14 RA-PH is required for inhibition of insulin signaling To probe the contributions of the RA and PH domains to inhibition of insulin signaling by Grb10 and Grb14, we transiently transfected wild-type Grb10 or Grb14, or selected point mutants, into Chinese hamster ovary cells stably transfected with the insulin receptor (CHO-IR) and monitored phosphorylation of Akt and extracellular signal-related kinase (ERK). These two serine/threonine kinases are activated through the phosphatidylinositol 3-kinase (PI-3K) and Ras pathways, respectively, subsequent to phosphorylation of insulin receptor substrate (IRS) proteins. Compared to the nontransfected control, introduction of wild-type Grb14 into CHO-IR cells markedly diminished insulin-stimulated Akt phosphorylation (Fig. 5a ). Both the RA (K140A) and PH (K252A) domain mutations compromised the ability of Grb14 to inhibit Akt activation. Mutation of the dimerization interface in the C-terminal helical extension to the PH domain also resulted in loss of inhibition (Fig. 5a, QNAA) . Compared to Grb14, Grb10 was a much less potent inhibitor of Akt activation. For inhibition of ERK phosphorylation, the results are similar, if less pronounced (Fig. 5a ). Again, Grb14 was a more potent inhibitor of ERK phosphorylation than Grb10 was, and point mutations in the Grb14 RA domain (K140A), PH domain (K252A) or the RA-PH dimerization interface (QNAA) compromised the inhibitory effect of Grb14. Grb10 was also a poor inhibitor of insulin-stimulated ERK phosphorylation.
Presumably, the inability of Grb14 to attenuate insulin signaling upon mutation of the RA or PH domain is due to less efficient recruitment of Grb14 to the insulin receptor. To test this, we performed co-immunoprecipitation experiments in CHO-IR cells transfected with wild-type or mutant Grb14. The Grb14 point mutations K140A (RA domain) and K252A (PH domain) resulted in a partial loss of interaction between Grb14 and the insulin receptor (Fig. 5b) , although there was no appreciable difference in receptor association for the RA-PH dimerization mutant (QNAA). Compared to Grb14, Grb10 interacts poorly with the insulin receptor ( Fig. 5b) , consistent with its weaker ability to inhibit insulin signaling (Fig. 5a) . Because the co-immunoprecipitation experiment is performed with detergentsolubilized membranes, we also performed fluorescence microscopy studies on intact CHO-IR cells transfected with GFP-Grb14, which showed that GFP-Grb14 K252A remains in the cytoplasm upon insulin stimulation, in contrast to wild-type GFP-Grb14, which translocates to the plasma membrane ( Supplementary Fig. 5 ).
DISCUSSION
After insulin stimulation, the insulin receptor is downregulated by several mechanisms, including dephosphorylation by protein tyrosine phosphatases such as PTP1B 28, 29 and binding of the adaptor protein Grb14 (ref. 7) . The BPS region in Grb14 directly inhibits the catalytic activity of the insulin receptor by binding as a pseudosubstrate in the kinase active site, and the C-terminal SH2 domain binds to the phosphorylated activation loop 10 .
Our current structural and biochemical studies focused on the RA and PH domains of Grb10 and Grb14 and demonstrated that they, in addition to the BPS region and SH2 domain, are required for inhibition of insulin signaling by Grb14 (Fig. 5a) .
The crystal structure of Grb10 RA-PH reveals that these two domains, separated in sequence by B40 residues, nevertheless physically associate to form a single structural unit. The RA-PH interface is conserved in Grb14 and Grb7. We propose that the role of the integrated RA-PH structural unit is to optimize binding of small GTPases (for example, Ras) at the plasma membrane. That is, binding of the PH domain to membrane phosphoinositides will favorably position the structurally coupled RA domain for binding to membraneanchored GTPases. As judged from the Grb14-Ras-insulin receptor structural model (Fig. 6) , the particular mechanism of membrane anchoring of a GTPase-N-terminal (for example, Arf proteins) versus C-terminal (for example, Ras proteins), length of the tether-could dictate whether a given GTPase will interact with an RA-PH unit, in addition to the intrinsic GTPase-RA domain binding affinity. For example, the Rap1 C-terminal tail is seven residues shorter than that of N-Ras, which could explain, in part, why Rap1 binds poorly to Grb14 (data not shown) and Grb7 (ref. 26) .
Most PH domains bind to membrane phosphoinositides and do so with modest affinities 21 . The measured binding affinities to the Grb10 PH domain are in the 4-10 mM K d range (for PIP 2 and PIP 3 , Table 2 ), whereas for the Grb14 PH domain the range is Z30 mM. The sequences of the Grb10 and Grb14 PH domains, particularly a glutamic acid in the b1-b2 loop (Glu243 in Grb10) ( Fig. 3c) , suggest that these PH domains may bind phosphoinositides noncanonically 20 . The mutagenesis data ( Table 2) , although not unequivocal, indicate that the Grb10 PH domain binds phosphoinositides noncanonically, but that the Grb14 PH domain may bind phosphoinositides canonically. Because Grb14 RA-PH showed modest in vitro specificity toward PI(3,4,5)P 3 (Fig. 3b) , we tested whether wortmannin, an inhibitor of PI-3K, affects the ability of Grb14 to be recruited to the insulin receptor. The co-immunoprecipitation results (data not shown) suggest that PI-3K activity is not required for Grb14 recruitment to the receptor.
Notably, PH domains have been implicated in binding directly to activated GTPases 30 , raising the question of whether the Grb14 PH domain (which binds phosphoinositides weakly) could bind directly to GTPases together with the RA domain. Given the relative position of the RA and PH domains in the Grb10 RA-PH structure and the mode of GTPase binding to an RA domain 18, 27 (with corroboration from the Grb14 K140A result (Fig. 4b) ), a direct interaction between the Grb14 PH domain and a GTPase seems unlikely.
Grb14 associates more strongly to activated Ras than Grb10 does (Fig. 4a) , although it is not clear from the Grb10 RA-PH structure and a sequence comparison of the RA domains why this might be so. Because membrane recruitment via the PH domain is important for the interaction of Grb14 with Ras ( Fig. 4b, K252A) , differences in the phosphoinositide-binding characteristics of the PH domains of Grb10 and Grb14 might account for their differential ability to interact with Ras. It is conceivable that the higher-affinity (and more promiscuous) PH domain of Grb10 results in recruitment to different regions of the plasma membrane than the PH domain of Grb14, or perhaps to internal membranes. Of note, dimerization of the RA-PH unit through the C-terminal extension of the PH domain will increase membrane-binding avidity 21 . Although Grb10 RA-PH only weakly dimerizes in solution ( Supplementary Fig. 4) , dimerization of the Grb10 or Grb14 SH2 domain 10, 31 , along with membrane association of the PH domain, will facilitate the formation of the RA-PH dimer.
Our functional studies monitoring Akt and ERK activation downstream of insulin stimulation demonstrated that Grb14 is a more potent inhibitor of insulin signaling than Grb10 is (Fig. 5a) , at least in CHO-IR cells, which is probably due to more efficient recruitment of Grb14 to the insulin receptor ( Fig. 5b) . Previous biochemical experiments showed that the Grb14 BPS region is a more potent inhibitor (and thus better binder) of the insulin receptor than the Grb10 BPS region 32 . Our data demonstrating that Grb10 is a weak binder of Ras compared to Grb14 (Fig. 4a) , and that GTPase association is evidently necessary for full recruitment of Grb14 to the insulin receptor ( Fig. 5b,  K140A) , indicate that the RA-PH unit of Grb14 also contributes to its inhibitory signaling potency versus Grb10. In light of these biochemical results for Grb10, it is unexpected that Grb10 À/À mice have an improved insulin-signaling phenotype 4,5 , although the expression levels of Grb10 versus Grb14 in insulin-responsive cells has not been characterized.
The tandem RA-PH domains of Grb7, Grb10 and 14 are conserved in a second adaptor protein family (MRL proteins 11 ), which comprises the Caenorhabditis elegans protein MIG-10 (ref. 12), the mammalian proteins RIAM 13, 14 and lamellipodin 12 and the Drosophila melanogaster protein Pico 12 , which are involved in actin-cytoskeleton rearrangement. Genetic evidence indicates that MIG-10 interacts with the small GTPase CED-10 (Rac1 ortholog) 33 . RIAM, although named for its ability to interact with Rap1 (ref. 13) , was shown in a different study to bind instead to Ras 14 . Despite efforts to do so, no small GTPase has been identified as a lamellipodin binder 15 . The PH domains of RIAM and lamellipodin, like those of Grb10 and Grb14, contain an acidic residue in the b1-b2 loop (Glu243 in Grb10, Supplementary Fig. 2) , which suggests that these PH domains might bind phosphoinositides via the noncanonical mode. Whether in RA-PH-containing proteins the Figure 6 Model of the interaction between Grb14, Ras and the insulin receptor. The two insulin receptor kinase (IRK) domains are shown in surface representation (opaque), colored dark (N lobe) and light (C lobe) gray. The juxtamembrane regions linking the transmembrane helices to the kinase domains are colored black. Grb14 is shown in ribbon representation with a semitransparent surface. The RA domain is colored violet, the PH domain cyan, the BPS region orange and the SH2 domain green. The interdomain linker regions are gray. Two Ras molecules (blue) are shown in ribbon representation with semitransparent surfaces. The bound nucleotide (GMPPNP) is shown in sphere representation and colored black. Starting from the structure of IRK-Grb14(BPS) (PDB 2AUH) 10 (two copies), the dimeric SH2 domain of Grb14 (PDB 2AUG) 10 was docked onto the two IRK molecules based on the structure of IRK-APS(SH2) (PDB 1RQQ) 34 . The molecular twofold axis of the SH2 dimer is perpendicular to the plane of the membrane (half of a lipid bilayer is depicted to scale). Ras was docked onto Grb10 RA-PH using the structure of the Ras-RalGDS(RA) complex (PDB 1LFD) 27 . The twofold axis of RA-PH is perpendicular to the membrane (oriented as in Fig. 1b, left) . The juxtamembrane region of the insulin receptor, the interdomain linkers of Grb14 and the C-terminal tail of N-Ras were modeled using stereochemically realistic polypeptide segments. For the C-terminal segment of N-Ras, residues Lys167-Cys181 (the site of palmitoylation, 5 residues N-terminal to the CAAX box) are modeled in an extended conformation. Because of the degrees of freedom inherent in assembling the model, it is difficult to speculate whether Ras might interact directly with IRK or the Grb14 BPS region.
phosphoinositide-binding mode influences GTPase binding or specificity remains to be determined.
In response to insulin, a number of cellular signaling pathways are activated, including the PI-3K and ERK pathways, which are then attenuated at the level of the insulin receptor by PTP1B and Grb14. The mechanisms that govern the kinetics of insulin signaling are not well understood, in particular, how the duration of positive signaling is controlled. Dephosphorylation of the insulin receptor by endoplasmic reticulum-tethered PTP1B is thought to require endocytosis of the receptor, and the timescale for this process (minutes) provides a window of opportunity for recruitment and phosphorylation of IRS proteins to activate the PI-3K and ERK pathways. In contrast, the negative regulator Grb14 is a multidomain cytoplasmic adaptor protein, not unlike the PH-PTB-containing IRS proteins, which binds to the phosphorylated (activated) kinase domain of the insulin receptor. We have shown here that Grb14-mediated inhibition of insulin signaling requires functional RA and PH domains, and that Grb14 can bind to activated Ras. Therefore, an attractive hypothesis is that Ras activation serves as a timing mechanism for the negativefeedback inhibition of insulin signaling by Grb14.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Accession codes. Protein Data Bank: Atomic coordinates and structure factors for Grb10 RA-PH have been deposited with the accession code 3HK0.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
